Abbott Labs’ surprise guidance bump is a major positive for its shareholders

Earnings

An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.
Abbott Labs

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016.

Articles You May Like

Could Trump reinstate the student debt that Biden forgave? Here’s what experts say
Older voters prioritized personal economic issues, helped Republicans win on Election Day, new AARP poll finds
McDonald’s to invest more than $100 million to speed up recovery after E. coli outbreak
Eli Manning, Derek Jeter, Jimmy Fallon join TGL New York Golf Club investor group
Lowe’s beats on earnings and hikes guidance, but still expects sales to fall this year

Leave a Reply

Your email address will not be published. Required fields are marked *